Sarepta Therapeutics, Inc. (SRPT) SEC Filing 8-K Material Event for the period ending Wednesday, October 24, 2018

Sarepta Therapeutics, Inc.

CIK: 873303 Ticker: SRPT

View differences made from one to another to evaluate Sarepta Therapeutics, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Sarepta Therapeutics, Inc..


Assess how Sarepta Therapeutics, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Sarepta Therapeutics, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

Sarepta Therapeutics, Inc. provided additional information to their SEC Filing as exhibits

Ticker: SRPT
CIK: 873303
Form Type: 8-K Corporate News
Accession Number: 0001564590-18-024894
Submitted to the SEC: Wed Oct 24 2018 4:13:07 PM EST
Accepted by the SEC: Wed Oct 24 2018
Period: Wednesday, October 24, 2018
Industry: Pharmaceutical Preparations
  1. Financial Exhibit
  2. Other Events

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: